Abstract
Several studies have shown a correlation between obstructive sleep apnea (OSA) and obesity, as well as obesity and diabetes mellitus. This is probably related to the fact that patients with OSA are likely to have a high prevalence of the risk factors that comprise metabolic syndrome. It has been shown that sleep deprivation when induced experimentally can cause glucose intolerance and many studies have established the association between sleep apnea and type two diabetes mellitus. There is also a proven association between snoring and sleep apnea as well as snoring and metabolic syndrome. In the current article we review the patho-physiology of hyperglycemia, insulin resistance due to sleep apnea, and treatment of OSA with continuous positive airway pressure therapy. Continuous positive airway pressure (CPAP) does, in fact, lead to improvement in insulin resistance and lowered hemoglobin A1C levels. The question that remains to be answered is whether the association between sleep apnea and the components of metabolic syndrome is one of co-existence or causality, but it can no longer be denied that there is a strong relationship which should lead to investigation of one if the other is found.
Keywords: Sleep apnea, sleep disordered breathing, diabetes mellitus, hyperglycemia, apnea
Current Respiratory Medicine Reviews
Title: Association of Sleep Apnea Syndrome and Diabetes Mellitus
Volume: 3 Issue: 4
Author(s): Salim Surani and Joseph Varon
Affiliation:
Keywords: Sleep apnea, sleep disordered breathing, diabetes mellitus, hyperglycemia, apnea
Abstract: Several studies have shown a correlation between obstructive sleep apnea (OSA) and obesity, as well as obesity and diabetes mellitus. This is probably related to the fact that patients with OSA are likely to have a high prevalence of the risk factors that comprise metabolic syndrome. It has been shown that sleep deprivation when induced experimentally can cause glucose intolerance and many studies have established the association between sleep apnea and type two diabetes mellitus. There is also a proven association between snoring and sleep apnea as well as snoring and metabolic syndrome. In the current article we review the patho-physiology of hyperglycemia, insulin resistance due to sleep apnea, and treatment of OSA with continuous positive airway pressure therapy. Continuous positive airway pressure (CPAP) does, in fact, lead to improvement in insulin resistance and lowered hemoglobin A1C levels. The question that remains to be answered is whether the association between sleep apnea and the components of metabolic syndrome is one of co-existence or causality, but it can no longer be denied that there is a strong relationship which should lead to investigation of one if the other is found.
Export Options
About this article
Cite this article as:
Surani Salim and Varon Joseph, Association of Sleep Apnea Syndrome and Diabetes Mellitus, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359850
DOI https://dx.doi.org/10.2174/157339807782359850 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
Current Vascular Pharmacology Ameliorative Potentials of Methanol Fractions of <i>Cnidoscolus aconitifolius</i> on Some Hematological and Biochemical Parameters in Streptozotocin Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
Current Pharmaceutical Design The Evidence Base for Revascularisation of Chronic Total Occlusions
Current Cardiology Reviews Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Increased OPG Expression and Impaired OPG/TRAIL Ratio in the Aorta of Diabetic Rats
Medicinal Chemistry Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin
Current Metabolomics Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with <sup>90</sup>Y-DOTATOC: Associations with Risk Factors
Current Radiopharmaceuticals Proteomic Analysis of the Vitreous Body in Proliferative and Non-Proliferative Diabetic Retinopathy
Current Proteomics Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk
Current Pharmaceutical Design Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry General Aspects of Metal Toxicity
Current Medicinal Chemistry Correlations Between Carotid IMT, Factor VIII Activity Level and Metabolic Disturbances: A Cardio-Vascular Risk Factor in the HIV Positive Persons
Current HIV Research Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Current Diabetes Reviews Is there U-turn from Insulin Back to Pills in Diabetes?
Current Vascular Pharmacology Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Mini-Reviews in Medicinal Chemistry